# Takeda invests €100M in Linz biologics production site

Takeda will invest €100 million by 2025 in its Linz, Austria production site, including a new syringe production line for biologics treating chronic inflammatory bowel diseases. The line is expected to start production in fiscal year 2024.

- Type: Investment
- Announced: 2023-05-26
- Where: Linz, Austria
- Value: $109.0M (100.0M EUR)
- Starts operating: 2024
- Status: announced
- Products: biologics for chronic inflammatory bowel diseases, syringe production line
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Takeda](https://endata.com/companies/52956.md)

## Sources

- [tips.at](https://www.tips.at/nachrichten/linz/wirtschaft-politik/606407-takeda-investiert-100-millionen-euro-in-den-produktionsstandort-linz), 2023-05-26: "Bis zum Jahr 2025 will Arzneimittelhersteller Takeda 100 Millionen Euro in den Produktionsstandort Linz investieren, um den langfristigen Fokus auf die Herstellung von Biologika zur Behandlung chronisch entzündlicher Darmerkrankungen weiter zu stärken."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.